Egypt: "Animal Health Research" reached a third of the vaccine for "bird flu"

Sunday, July 11th, 2010 - 15:23

Flag of "The Seventh Day" that the Institute of Animal Health Research to reach production of a new local vaccine to combat bird flu h5n1 influenza is endemic in Egypt since he was Egypt in 2006.

Informed sources said the Ministry of Agriculture and Land Reclamation to produce the new vaccine will be within two years from now, will be in collaboration with the company, "Biological Products" where the company creates new line for production of a local vaccine against bird flu.

The sources revealed that the General Authority for Veterinary Services refused to file the Faculty of Veterinary Medicine, Cairo University and Harbin Institute of China, local production of a vaccine strain of Egypt after the withdrawal of samples and testing them for non-completion of his papers.

The sources for the "seventh day" that the Commission examine the files Authority requested the Working Group and the Harbin Institute report on the results of the new vaccine in the country of origin "Egypt" which is not available so far, which is also what happened with the vaccine produced by the National Center for Research.

The sources said that unidentified bodies aborted production of a vaccine Faculty of Veterinary Medicine and the Institute of Harbin, for vaccine production Animal Health Research Institute, noted that the vaccine Faculty of Veterinary Medicine has proven its effectiveness and its consequences.

The Animal Health Research Institute of the Ministry of Agriculture and Land Reclamation is to reach the third to produce a vaccine against bird flu, but after a long struggle with the body and importers halt the production of the vaccine altogether.

With a team of scientists, Faculty of Veterinary Medicine, Cairo University in collaboration with the Institute of "Harbin" Veterinary Research in China to prepare for a new vaccine for the prevention of bird flu.

And Dr Ahmed Abdul Ghani Elsnose Professor of Virology and one of the scientists of the research team that the new vaccine strain was isolated from Egypt in 2009 has been tested and proved a success in the treatment and prevention of disease by 100%.